retatrutide phase 2 trial results obesity Perceived benefits of treatment for with retatrutide: A qualitative study of patients in a clinical Retatrutide Phase 3: TRIUMPH Program – Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon

Hepatology 57 , 716726 (2013)

10.1104/pp.009886 54 GongQ.YangZ.ChenE.SunG.HeS.ButtH

No difference in the incidence of urinary tract infection (UTI), upper respiratory tract infection (URTI), nasopharyngitis, and headache was evident between GLP-1 analogues and sitagliptin

doi: 10.3389/fendo.2024.1503905 Received 29 September 2024 Accepted 09 December 2024 Published 09 January 2025 Volume 15 - 2024 Edited by Weibin Bai, Jinan University, China Reviewed by Zia Ur Rehman, University of Agriculture, Pakistan Kamil Gill, Pomeranian Medical University, Poland Updates Copyright 2025 Saleh, Sallam, Elsuity, Dutta, Sengupta and Nasr

PlexusDx serves all 50 states without insurance requirements, and HSA/FSA funds are eligible, making flexible, personalized treatment affordable